These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 14810077)
21. Is methylergonovine tartrate superior to ergonovine maleate? MOORE JH Am J Obstet Gynecol; 1956 Apr; 71(4):908-11. PubMed ID: 13302331 [No Abstract] [Full Text] [Related]
23. The use of Di-hydro-ergotamine in obstetrics. GILL RC Med J Aust; 1951 Mar; 1(10):373-6. PubMed ID: 14826192 [No Abstract] [Full Text] [Related]
24. Further experience with methergine as an oxytocic. BASKIN MJ Rocky Mt Med J; 1949 Apr; 46(4):304. PubMed ID: 18115577 [No Abstract] [Full Text] [Related]
25. [Obstetrical use of ergot alkaloids]. Ugeskr Laeger; 1953 Feb; 115(8):309-10. PubMed ID: 13077866 [No Abstract] [Full Text] [Related]
26. THE METABOLITES OF ERGOMETRINE AND LYSERGIC ACID DIETHYLAMIDE IN RAT BILE. SLAYTOR MB; WRIGHT SE J Med Pharm Chem; 1962 May; 5():483-91. PubMed ID: 14056385 [No Abstract] [Full Text] [Related]
27. A study of the use of intravenous ergometrine in the third stage of labour. SNAITH L J Obstet Gynaecol Br Emp; 1951 Aug; 58(4):633-9. PubMed ID: 14880982 [No Abstract] [Full Text] [Related]
28. The Usage of Ergot ( Smakosz A; Kurzyna W; Rudko M; Dąsal M Toxins (Basel); 2021 Jul; 13(7):. PubMed ID: 34357964 [TBL] [Abstract][Full Text] [Related]
29. Metabolites of LSD and ergometrine. SLAYTOR M; PENNEFATHER JN; WRIGHT SE Experientia; 1959 Mar; 15(3):111. PubMed ID: 13652949 [No Abstract] [Full Text] [Related]
30. [Lysergic acid ethylamide, a new ergot drug strongly sedative effect causing psychotic states]. SOLMS H Schweiz Med Wochenschr; 1953 Apr; 83(15):356-60. PubMed ID: 13076048 [No Abstract] [Full Text] [Related]
31. [Use of dihydroergotamine in obstetrics]. MONCKEBERG G Bol Soc Chil Obstet Ginecol; 1951 Aug; 16(5):134-41. PubMed ID: 14878759 [No Abstract] [Full Text] [Related]
32. Specificity of the antibody receptor site to D-lysergamide: model of a physiological receptor for lysergic acid diethylamide. Van Vunakis H; Farrow JT; Gjika HB; Levine L Proc Natl Acad Sci U S A; 1971 Jul; 68(7):1483-7. PubMed ID: 5283939 [TBL] [Abstract][Full Text] [Related]
33. [Effects of diethylamide of lysergic acid on the psychic symptoms of schizophrenia; psychopathological study]. CALLIERI B; RAVETTA M Rass Studi Psichiatr; 1955; 44(1):39-88. PubMed ID: 13246040 [No Abstract] [Full Text] [Related]
34. Effects of mescaline and lysergic acid (d-LSD-25). HOCH PH; CATTELL JP; PENNES HH Am J Psychiatry; 1952 Feb; 108(8):579-84. PubMed ID: 14903183 [No Abstract] [Full Text] [Related]
35. [Experience with dihydroergotamine in obstetrics]. PEREZ ML; GADEA RE Rev Obstet Ginecol Venez; 1955; 15(2):881-5. PubMed ID: 13336773 [No Abstract] [Full Text] [Related]
36. [Contribution to the use of methergin in obstetrics]. LOPEZ HERNANDEZ RJ Rev Esp Obstet Ginecol; 1952; 11(66):391-412. PubMed ID: 13056318 [No Abstract] [Full Text] [Related]
37. The antagonism between 5-hydroxytryptamine and certain derivatives of lysergic acid. SAVINI EC Br J Pharmacol Chemother; 1956 Sep; 11(3):313-7. PubMed ID: 13364207 [No Abstract] [Full Text] [Related]
38. PROPHYLACTIC TREATMENT OF MIGRAINE BY MEANS OF LYSERGIC ACID DERIVATIVES. SICUTERI F Triangle; 1963 Oct; 6():116-25. PubMed ID: 14087164 [No Abstract] [Full Text] [Related]
39. The obstetrical use of ergot: a violation of the doctrine "primum non nocere". RINGROSE CA Can Med Assoc J; 1962 Sep; 87(13):712-4. PubMed ID: 14492373 [No Abstract] [Full Text] [Related]
40. [Active obstetrical third stage in hospital]. DES ROSIERS L Union Med Can; 1955 Nov; 84(11):1274-6. PubMed ID: 13282010 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]